BASF's (ETR:BAS) Returns Have Hit A Wall

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. Although, when we looked at BASF (ETR:BAS), it didn't seem to tick all of these boxes.

Advertisement

What Is Return On Capital Employed (ROCE)?

For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. The formula for this calculation on BASF is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.09 = €6.0b ÷ (€86b - €20b) (Based on the trailing twelve months to March 2023).

Thus, BASF has an ROCE of 9.0%. On its own, that's a low figure but it's around the 10% average generated by the Chemicals industry.

View our latest analysis for BASF

roce
XTRA:BAS Return on Capital Employed May 3rd 2023

Above you can see how the current ROCE for BASF compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free report on analyst forecasts for the company.

SWOT Analysis for BASF

Strength
  • Debt is well covered by earnings and cashflows.
  • Dividend is in the top 25% of dividend payers in the market.
Weakness
  • No major weaknesses identified for BAS.
Opportunity
  • Expected to breakeven next year.
  • Has sufficient cash runway for more than 3 years based on current free cash flows.
  • Good value based on P/S ratio and estimated fair value.
Threat
  • Dividends are not covered by cash flow.

How Are Returns Trending?

Over the past five years, BASF's ROCE and capital employed have both remained mostly flat. Businesses with these traits tend to be mature and steady operations because they're past the growth phase. So unless we see a substantial change at BASF in terms of ROCE and additional investments being made, we wouldn't hold our breath on it being a multi-bagger. With fewer investment opportunities, it makes sense that BASF has been paying out a decent 58% of its earnings to shareholders. Given the business isn't reinvesting in itself, it makes sense to distribute a portion of earnings among shareholders.

Our Take On BASF's ROCE

In a nutshell, BASF has been trudging along with the same returns from the same amount of capital over the last five years. And in the last five years, the stock has given away 29% so the market doesn't look too hopeful on these trends strengthening any time soon. In any case, the stock doesn't have these traits of a multi-bagger discussed above, so if that's what you're looking for, we think you'd have more luck elsewhere.

On a final note, we found 2 warning signs for BASF (1 makes us a bit uncomfortable) you should be aware of.

While BASF isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

Valuation is complex, but we're here to simplify it.

Discover if BASF might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About XTRA:BAS

BASF

Operates as a chemical company worldwide.

Good value with acceptable track record.

Advertisement

Weekly Picks

DA
davidlsander
OPTH logo
davidlsander on Optimi Health ·

OPTH: A licensed manufacturer already selling MDMA while peers still wait on trials

Fair Value:US$1259.6% undervalued
11 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
FU
VRT logo
FundamentalFlow on Vertiv Holdings Co ·

The Short and Long Term Compounder of Liquid Cooling industry.

Fair Value:US$45040.0% undervalued
4 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
JO
John_Eric
SPXC logo
John_Eric on SPX Technologies ·

I Fell in Love With a Data-Center Cooling Stock. Then I Opened the Filings.

Fair Value:US$2034.6% overvalued
5 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
TR
tripledub
GQG logo
tripledub on GQG Partners ·

The Cheap Genius Problem

Fair Value:AU$2.4541.2% undervalued
13 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative

Updated Narratives

ES
LAGENDA logo
Ester on Lagenda Properties Berhad ·

Lagenda Properties 录得创纪录销售额与收入,推动盈利能见度提升

Fair Value:RM 2.543.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
RockeTeller
STLR logo
RockeTeller on STLLR Gold ·

STLLR Gold, Eric Sprott + Agnico Backed: Massive Canadian Gold Developer at Junior Prices

Fair Value:CA$102.2298.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
PE
RYTM logo
peter_4mgsy on Rhythm Pharmaceuticals ·

High-Growth Emerging Commercial Stage Biotech

Fair Value:US$13413.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
289 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9120.5% overvalued
153 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0941.5% undervalued
174 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative